Total Payments
$73,450
2021 Payments
$2,400
Companies
8
Transactions
78
Payment Breakdown by Category
Other$62,100 (84.5%)
Consulting$7,475 (10.2%)
Food & Beverage$2,054 (2.8%)
Travel$1,668 (2.3%)
Education$153.41 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $61,500 | 25 | 83.7% |
| Consulting Fee | $7,475 | 1 | 10.2% |
| Food and Beverage | $2,054 | 37 | 2.8% |
| Travel and Lodging | $1,668 | 8 | 2.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $600.00 | 1 | 0.8% |
| Education | $153.41 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $72,444 | 68 | $0 (2021) |
| ViiV Healthcare Company | $600.00 | 1 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $223.20 | 4 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $121.21 | 1 | $0 (2019) |
| Astute Medical, Inc. | $18.44 | 1 | $0 (2018) |
| EKOS Corporation | $17.77 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.89 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $12.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $2,400 | 2 | GlaxoSmithKline, LLC. ($2,400) |
| 2020 | $10,024 | 8 | GlaxoSmithKline, LLC. ($10,024) |
| 2019 | $37,198 | 44 | GlaxoSmithKline, LLC. ($36,476) |
| 2018 | $23,580 | 18 | GlaxoSmithKline, LLC. ($23,543) |
| 2017 | $249.09 | 6 | Teva Pharmaceuticals USA, Inc. ($223.20) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/12/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 01/12/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 10/20/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 04/14/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: RESPIRATORY | ||||||
| 03/18/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 03/12/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Travel and Lodging | Cash or cash equivalent | $31.38 | General |
| Category: RESPIRATORY | ||||||
| 03/06/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 03/05/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $92.50 | General |
| Category: RESPIRATORY | ||||||
| 02/19/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $2.56 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $111.04 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $106.64 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Travel and Lodging | Cash or cash equivalent | $31.60 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $103.13 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2019 | GlaxoSmithKline, LLC. | — | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $600.00 | General |
| 09/13/2019 | ViiV Healthcare Company | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
About Dr. Robert Promisloff, D.O
Dr. Robert Promisloff, D.O is a Pulmonary Disease healthcare provider based in Wynnewood, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487635587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Promisloff, D.O has received a total of $73,450 in payments from pharmaceutical and medical device companies, with $2,400 received in 2021. These payments were reported across 78 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($61,500).
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Wynnewood, PA
- Active Since 11/07/2005
- Last Updated 08/31/2016
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1487635587
Products in Payments
- TRELEGY ELLIPTA (Drug) $30,040
- NUCALA (Biological) $29,606
- ANORO (Drug) $3,600
- DUPIXENT (Biological) $121.21
- CINQAIR (Drug) $114.96
- Nephrocheck (Device) $18.44
- EKOSONIC (Device) $17.77
- BREO (Drug) $13.94
- STIOLTO (Drug) $13.89
- SYMBICORT (Drug) $12.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Wynnewood
Thomas Meyer, M.d, M.D
Pulmonary Disease — Payments: $503,728
Pulmonary Disease $503,728
Jacqueline Sutter, D.o, D.O
Pulmonary Disease — Payments: $184,280
Pulmonary Disease $184,280
Rochelle Goldberg, Md, MD
Pulmonary Disease — Payments: $12,384
Pulmonary Disease $12,384
Lauren Rome, M.d, M.D
Pulmonary Disease — Payments: $12,115
Pulmonary Disease $12,115
Dr. Gregory Lenchner, M.d, M.D
Pulmonary Disease — Payments: $11,762
Pulmonary Disease $11,762
Catherine Kuntz, M.d, M.D
Pulmonary Disease — Payments: $7,462
Pulmonary Disease $7,462